Overview

• The ban restricts new prescriptions of puberty blockers for minors, allowing them only in clinical trials or for those already receiving treatment.
• The High Court's decision was based on the Cass Review, which highlighted weak evidence supporting the use of puberty blockers.
• TransActual, a trans advocacy group, plans to appeal the ruling, arguing the ban was implemented without proper consultation.
• Health Secretary Wes Streeting supports the ruling but emphasizes the need for evidence-led healthcare and is initiating a new clinical trial.
• The ban, initially temporary, may become permanent under the current Labour government.